Cargando…
Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H
Botulinum neurotoxins (BoNTs), which have been exploited as cosmetics and muscle-disorder treatment medicines for decades, are well known for their extreme neurotoxicity to humans. They pose a potential bioterrorism threat because they cause botulism, a flaccid muscular paralysis-associated disease...
Autores principales: | Yao, Guorui, Lam, Kwok-ho, Perry, Kay, Weisemann, Jasmin, Rummel, Andreas, Jin, Rongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371848/ https://www.ncbi.nlm.nih.gov/pubmed/28282873 http://dx.doi.org/10.3390/toxins9030093 |
Ejemplares similares
-
A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding
por: Yao, Guorui, et al.
Publicado: (2017) -
A viral-fusion-peptide-like molecular switch drives membrane insertion of botulinum neurotoxin A1
por: Lam, Kwok-ho, et al.
Publicado: (2018) -
Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H
por: Hackett, Gavin, et al.
Publicado: (2018) -
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
por: Weisemann, Jasmin, et al.
Publicado: (2016) -
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
por: Yao, Guorui, et al.
Publicado: (2016)